Research location
Toyoake
Japan
Advertisement
Research activity in Toyoake
JapanCureCurrent currently publishes aggregate city-level research activity for this location: 30 trials and 30 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Toyoake
30 linked trials · page 1 of 1A Study of Brenipatide in Adult Participants With SchizophreniaNCT07410507 · 2026-02-10 · 1 site observation
RECRUITING
Zephyr Valve Japan Post-Marketing SurveillanceNCT06332885 · 2024-03-12 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung CancerNCT05388669 · 2022-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI TherapyNCT05338970 · 2022-07-08 · 1 site observation
ACTIVE_NOT_RECRUITING
The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)NCT04818983 · 2021-04-07 · 1 site observation
COMPLETED
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)NCT04656652 · 2020-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective DisorderNCT04512066 · 2020-09-08 · 1 site observation
COMPLETED
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)NCT04501497 · 2020-08-21 · 1 site observation
COMPLETED
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionNCT04273945 · 2020-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Mid-Q Response StudyNCT04180696 · 2020-01-23 · 1 site observation
COMPLETED
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)NCT04808518 · 2019-12-10 · 1 site observation
COMPLETED
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanNCT04034095 · 2019-07-08 · 1 site observation
COMPLETED
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative SymptomsNCT03669640 · 2018-12-04 · 1 site observation
TERMINATED
Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)NCT03675776 · 2018-10-30 · 1 site observation
TERMINATED
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)NCT03645330 · 2018-08-15 · 1 site observation
COMPLETED
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT DevicesNCT03366545 · 2018-05-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaNCT03230864 · 2017-07-20 · 1 site observation
TERMINATED
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYSTNCT02657356 · 2016-10-04 · 1 site observation
TERMINATED
AdaptResponse Clinical TrialNCT02205359 · 2014-08-01 · 1 site observation
COMPLETED
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaNCT01515423 · 2012-05-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Paliperidone Palmitate in Participants With SchizophreniaNCT01299389 · 2010-10-01 · 1 site observation
COMPLETED
Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))NCT01163292 · 2010-03-01 · 1 site observation
COMPLETED
A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisNCT00870467 · 2009-03-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)NCT00771251 · 2008-05-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyNCT00727987 · 2008-05-01 · 1 site observation
COMPLETED
A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With SchizophreniaNCT00396565 · 2006-07-01 · 1 site observation
COMPLETED
Special Survey on Parkinson's Disease Patients Treated Long-term Use of PramipexoleNCT00615914 · 2004-02-01 · 1 site observation
COMPLETED
Special Survey on PD Patients With Renal DysfunctionNCT00613756 · 2004-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.